Tonix Pharmaceuticals Holding Corp
General ticker "TNXP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.5M
Tonix Pharmaceuticals Holding Corp does not follow the US Stock Market performance with the rate: -40.5%.
Estimated limits based on current volatility of 29.0%: low 0.40$, high 0.73$
Short-term TNXP quotes
Long-term TNXP plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $7.77MM |
| Operating Expenses | $92.31MM | $112.09MM | $126.15MM |
| Operating Income | $-92.31MM | $-112.09MM | $-118.38MM |
| Non-Operating Income | $0.03MM | $1.87MM | $1.72MM |
| R&D Expense | $68.84MM | $81.88MM | $86.66MM |
| Income(Loss) | $-92.29MM | $-110.22MM | $-116.66MM |
| Profit(Loss) | $-92.29MM | $-110.22MM | $-116.66MM |
| Stockholders Equity | $218.72MM | $207.18MM | $105.53MM |
| Inventory | $7.73MM | $8.04MM | $14.15MM |
| Assets | $240.90MM | $225.69MM | $154.46MM |
| Operating Cash Flow | $-75.56MM | $-98.05MM | $-102.00MM |
| Capital expenditure | $35.31MM | $48.15MM | $7.89MM |
| Investing Cash Flow | $-35.31MM | $-48.15MM | $-29.07MM |
| Financing Cash Flow | $212.49MM | $87.84MM | $36.52MM |
| Earnings Per Share* | $-1,620.86 | $-640.26 | $-219.09 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.